FI
RYTM icon

Fosun International’s Rhythm Pharmaceuticals RYTM Stock Holding History

Fosun International’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-40,720
Closed -$883K – 282
2019
Q2 		$883K Buy
40,720
+11,000
+37% +$278K 0.06% 180
2019
Q1 		$887K Hold
29,720
– – 0.06% 172
2018
Q4 		$779K Buy
+29,720
New +$821K 0.05% 171

Other funds holding RYTM

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TG
TRV GP Boston, Massachusetts $18.9M AUM 541.67% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fosun International's RYTM Position: Q3 2019 in Review

Fosun International sold out of Rhythm Pharmaceuticals (RYTM) in Q3 2019, closing a stake of 40,720 shares — an estimated $883K sold.

Fosun International first reported a position in RYTM in Q4 2018 and held it in 3 quarters. The position peaked at $887K in Q1 2019. 84 funds tracked by Wall St. Rank hold RYTM as of Q3 2019.

  • Fosun International reported no remaining Rhythm Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Fosun International sold 40,720 Rhythm Pharmaceuticals shares in Q3 2019, an estimated $883K.
  • Fosun International first reported a position in Rhythm Pharmaceuticals in Q4 2018 and held it in 3 quarters.
  • Fosun International's Rhythm Pharmaceuticals position peaked at $887K in Q1 2019.
  • 84 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2019.

Based on Fosun International's 13F filing for Q3 2019, filed 12 Nov 2019.